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E-mail address: olgapc@bio.uminho.pt (O.P. CoutinWe investigated the antioxidant properties of two synthetic diarylamines, MJQ1 and MJQ2. For one of
them (MJQ1) the synthesis procedure is herein described. The compounds showed maximal protection
of ADP/Fe2+ induced mitochondrial lipid peroxidation for 50 nM (MJQ1) and 60 lM (MJQ2) concentra-
tions. Both compounds were also effective in the prevention of mitochondrial DW collapse. The effective
antioxidant dose of MJQ1 in mitochondria (50 nM) also proved to protect lipid peroxidation in PC12 cells
and the effect seems not to be related with the compound’s iron chelating ability. The modified structure
of MJQ1 clearly resulted in an improvement of its antioxidant and toxic profile, evaluated in mitochondria
and whole cells. This study demonstrates a high potential of these diarylamines, as radical scavengers,
whose chemical structures can be manipulated if a specific target is well characterized.
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Substantial evidence supports the active involvement of free
radicals in the development of several pathological conditions
including neurodegenerative and cardiovascular diseases, diabetes,
cancer or even normal aging (Lovell et al., 1995; Behl, 1999;
Schroeter et al., 2000; Jang and Surh, 2001; Valko et al., 2006). Mito-
chondria are involved in several processes essential for cell survival,
including energy production, redox control, calcium homeostasis,
and in some biosynthetic and metabolic pathways. However, it
has been recognized as the major source of ROS (reactive oxygen
species, which include O2, OH, H2O2) within the cell, being an
important target for oxidative damage. Mitochondrial or cytoplas-
mic ROS are able to attack the cellular components, includingmem-
brane lipids, proteins, and nucleic acids, leading to cell damage and/
or dysfunction and ultimately to cell death. Although the organisms
havemachinery of cellular defence, against oxidative stress, in some
pathological conditions they are not enough to remove the excess of
intracellular ROS (Bouchier-Hayes et al., 2005; Jezek and Hlavata,
2005). In the literature we can find abundant data about the
antioxidant activity of several natural compounds like phenolic




ho).plant-derived beverages such as tea and red wine (Schinella et al.,
2002; Pardo et al., 2005; Gulcin et al., 2006). However, their use as
active principles of drugs is very controversial. For that purpose,
compounds obtained by organic synthesis have many advantages
relatively to the natural ones: (1) their structures, precisely defined,
can be manipulated in order to improve their activity and direct
them to a specific target; (2) after establishment of the synthesis
procedure, they can be produced in a large scale and (3) they can
be obtained with a high degree of purity (Silva et al., 2006).
The secondary amines, particularly diarylamines obtained by
organic synthesis, were described as important molecules due to
their capacity as antioxidants, especially as radical scavengers
(Scott, 1988). However, a precise mechanism for their action has
not yet been clarified.
Information in the literature allowed some generalizations
about the relationship between the antioxidant activity and the
molecular structure of a compound. For instance, the presence of
donor groups in an aromatic ring was shown to enhance the anti-
oxidant activity, whereas groups that attract electrons, decrease
that activity (Scott, 1988).
The redox properties of some diarylamines, derived from dehy-
droabietic acid, were evaluated by cyclic voltammetry and their
free radical scavenging activity by the reduction of diphenyl-1-pic-
rylhydrazyl (DPPH) radical (Esteves et al., 2001). The authors
observed that the compounds that showed highest radical
scavenging activity and the lowest oxidation potential have a
p-methoxyphenyl moiety. In another study, the antioxidanty. All rights reserved.
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series, were evaluated. High antioxidant activity was found for
some of them, even better than those obtained for the classical
antioxidants, like the butylated hydroxyanisole (BHA) or butylated
hydroxytoluene (BHT), in terms of reducing power and radical
scavenging activity (Ferreira et al., 2006). These last results may
be indicative of a potential antioxidant capacity of diarylamines
in benzo[b]thiophene series, which we are now evaluating in bio-
logical models.
So, the aim of this study is to examine the potential antioxidant
properties of two new synthetic diarylamines (MJQ1 and MJQ2).
Both have a benzo[b]thiophene nucleus, but also some structural
differences, as can be seen in Fig. 1. The compound MJQ2 was syn-
thesized in 2004 (Queiroz et al., 2004) and biological activity
against Bacillus cereus and Candida albicans was shown, although
the mechanism behind this activity was not investigated at the
time. The compoundMJQ1 is a related compound (synthesis proce-
dure described herein) with a p-methoxyaniline group on the ben-
zene ring, whereas MJQ2 has an aminopyridine group and an ester
group on the thiophene ring. The relationship between these struc-
tural differences and their antioxidant capacity are now being
evaluated.
The biological approaches used to assess the antioxidant poten-
tial of these new molecules involved studies at the mitochondrial
level and studies with whole cells, namely the PC12 cell line. We
analysed the antioxidant capacity of these diarylamines on isolated
rat liver mitochondria subjected to oxidative stress, by the oxidant
pair ADP and iron, as well as their effect on mitochondrial bioener-
getics. As a complement of these studies in mitochondria, we eval-
uated the compounds effect on whole cells. The neuronal model of
PC12 was used to assess the effect of these diarylamines on ascor-
bate/iron-induced lipid peroxidation, usually associated with neu-
rodegenerative diseases (Pereira et al., 1999; Benedi et al., 2004;
Silva et al., 2006). Furthermore, we determined the diarylamines’
radical scavenging ability and metal ions chelating capacity (Fe3+
in particular), in order to better understand their mechanism of
action.
With this study we intend to provide useful data about cellular
targets for these new compounds, electing them by this way, as
good active principles to proceed further steps on the development
process of drugs, with pharmacological potential.
2. Materials and methods
2.1. Chemicals and reagents
Tetraphenylphosphonium (TPP+), sucrose and DOC were
obtained from Merck (Darmstadt, Germany). Trolox was obtained
from Sigma–Aldrich Chemie (Berlin, Germany). Fetal bovine serum
(FBS) was obtained from Biochrom KG (Berlin, Germany) and horse
serum was obtained from Gibco (Paisley, UK). All other reagents
were obtained from Sigma Chemical Company (St. Louis, EUA).
All solutions were prepared in Mili Q water.
Compounds in study, 6-(4-methoxyaniline)-2,3,7-trim-
ethylbenzo[b]thiophene (MJQ1) and ethyl 3-(3-aminopyri-
dine)benzo[b]thiophene-2-carboxylate (MJQ2) were synthesized
in the Department of Chemistry of the University of Minho (Braga,Fig. 1. Chemical structures of the diarylamines studied: MJQ1 (A) and MJQ2 (B).Portugal). The synthesis and characterization of compound MJQ2
was published in 2004 (Queiroz M-JRP et al., 2004) and the synthe-
sis of the MJQ1 compound follows below. Both diarylamines were
reconstituted in DMSO and maintained at 20 C, protected from
light.
2.2. Synthesis of MJQ1
The compound MJQ1 was synthesized using a palladium-cata-
lyzed CAN coupling. Column chromatography was performed on
Macherey-Nagel silica gel 230–400 mesh. ‘‘Petroleum ether” refers
to the fraction with boiling range 40–60 C. ‘‘Ether” refers to dieth-
ylether. rac.BINAP refers to the racemic mixture of 2,20-bis-(diphe-
nylphosphane) 1,10-binapthyl. The 1H NMR spectra was measured
on a Varian Unity Plus at 300 MHz. The 13C NMR spectra were mea-
sured in the same instrument at 75.4 MHz (using DEPT h 45). Ele-
mental analysis was determined on a LECO CHNS 932 elemental
analyser.
In a dry Schlenk tube, it was added under Ar, toluene (5 ml), 6-
bromo-2,3,7-benzo[b]thiophene (500 mg, 1,96 mmol), Pd(OAc)2
(13.2 mg, 0.0588 mmol), racBINAP (48.7 mg, 0.0784 mmol),
Cs2CO3 (894 mg, 2.74 mmol), p-methoxyaniline (254 mg,
2.06 mmol). The mixture was heated at 100 C for 22 h. After
cooling, ether was added and the filtrate was evaporated under
reduced pressure to give an oil, which was submitted to column
chromatography using solvent gradient from neat petroleum ether
to 20% ether/petroleum ether. The compound was obtained as a
white solid which was crystallized from ether/petroleum ether to
give colourless crystals (353 mg, 61%), m.p. 137–138 C. 1H NMR
(CDCl3) d 2.27 (3H, s, CH3), 2.40 (3H, s, CH3), 2.48 (3H, s, CH3),
3.80 (3H, s, OMe), 5.28 (1H, broad s, NH), 6.85 (4H, coalesced
ABq, 2´, 6´-H and 3´, 5´-H), 7.15 (1H, d J = 8.4 Hz, 5-H), 7.35 (1H,d
J = 8.4Hz, 4-H) ppm. 13C NMR (CDCl3) d 11.41 (CH3), 13.73 (CH3),
15.80 (CH3), 55.65 (OCH3), 114.69 (2 CH), 117.67 (CH), 119.13
(CH and 2 CH), 121.38 (C), 127.59 (C), 131.31 (C), 136.06 (C),
137.96 (C), 138.66 (C), 139.97 (C), 154.01 (C) ppm. Elemental anal-
ysis: C18H19NOS (297.415) requires: C, 72.69; H, 6.44; N, 4.71; S
10.78%. Found: C, 72.71; H, 6.42; N, 4.81; S, 10.76%.
2.3. Animals
The mitochondrial suspensions used in this work were isolated
from Wistar strain rats (males and females) overnight-fasted, with
2.5–3 months and 200–300 g of body weight. The rats were kept
under controlled light (12 h day/night cycle), temperature (22–
24 C), humidity (50–60%) conditions, and free access to water
(pH 5.5) and food. The experiments were carried out in accordance
with National Requirements for Vertebrate Animal Research and
with the European Convention for the protection of animals used
for experimental and other scientific purposes.
2.4. Isolation of rat liver mitochondria
Rat liver mitochondrial fractions were isolated by differential
centrifugation according to the method previously described by
Abreu et al., 2000. The final pellet was resuspended in 3–4 ml of
washing medium at a protein concentration of 30–40 protein/ml,
evaluated by the biuret method (Gornall et al., 1949), using bovine
serum albumin (BSA) as standard. All experiments were carried out
within a 5 h period, after isolation of mitochondrial fractions.
2.5. Oxygen consumption measurements
Oxygen consumption was monitored using a Clark-type oxygen
electrode (Yellow Springs Instruments, OH, USA) connected to a re-
corder (Kipp&Zonen, BD 112), in a thermostated water-jacketed
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mitochondrial suspension (1.5 mg) was incubated in 1 ml of the
reaction medium containing 125 mM sucrose, 65 mM KCl,
2.5 mM MgCl2, 5 mM KH2 PO4 and 10 mM HEPES (pH 7.2). The
reactions were initiated by adding the respiratory substrates
(10 mM glutamate/5 mM malate or 5 mM succinate). To induce
the respiratory state 3 (V3) ADP (125–250 nmol) was added. The
compounds, when present, were pre-incubated with the mito-
chondrial suspension, for 2 min, before substrate energization.
The respiratory parameters, respiratory control ratio (RCR) and
ADP/O ratio, were calculated according to Chance and Williams
(1956). The uncoupled respiration was measured in the presence
of 4 lg/ml oligomycin and 0.5 lM FCCP (carbonylcyanide4-trif-
luoromethoxyphenylhydrazone). The different velocities of mito-
chondrial respiration, namely V3, V4, oligomycin state (VOlig) and
FCCP state (VFCCP) were determined in order to study the effect of
the compounds on mitochondrial bioenergetics, as previously de-
scribed (Du et al., 1998).
2.6. Measurements of mitochondrial transmembrane electrical
potential (DW)
The determination of DW was made indirectly by the contin-
uous registration of the lipophilic cation tetraphenylphospho-
nium (TPP+) transport across the inner mitochondrial
membrane using a TPP+-selective electrode prepared in our lab-
oratory, in combination with a Ag/AgCl-saturated reference elec-
trode (model MI 402, Microelectrodes, Inc. Bedford, NH) (Kamo
et al., 1979). Both electrodes were immersed into the same
chamber and connected to a pH meter (model 3305; Jenway, Es-
sex, UK). The signals were simultaneously fed to a dual-trace
potentiometric recorder (model BD 121; Kipp & Zonen). Mito-
chondria (1–1.5 mg) were incubated in 1 ml of the reaction med-
ium containing 125 mM sucrose, 65 mM KCl, 2.5 mM MgCl2,
5 mM KH2PO4, 10 mM HEPES (pH 7.2) and 3 lM TPP+. The reac-
tion mixtures were continuously stirred and the temperature
maintained at 30 C. The respiratory substrates used were
10 mM glutamate/5 mM malate or 5 mM succinate (supple-
mented or not with 3 lM rotenone). The phosphorylation cycle
was initiated by the addition of ADP at a convenient concentra-
tion (125–250 nmol). When present, the compounds were incu-
bated with the mitochondrial suspension before the addition of
the ADP. The DW was determined assuming that the TPP+ distri-
bution between the mitochondria and the medium follows the
Nernst equation: DW (mV) = 59 log (v/V)  59 log (10DE/59  1),
in which t, V and DE are the mitochondrial volume, incubation
medium volume and deflection of the electrode potential from
the base line, respectively (Kamo et al., 1979). The matrix volume
was assumed as 1.1 ll/mg protein Masini et al. (1984). The pur-
pose of our experiments was to show relative changes in poten-
tials, so no correlation was made for the ‘‘passive” binding of
TPP+ to the mitochondrial membranes.
2.7. Mitochondrial lipid peroxidation
The evaluation of lipid peroxidation in mitochondria was done
using 3 different approaches:
2.7.1. Oxygen consumption measurements
The lipid peroxidation was indirectly measured by the oxygen
consumption, as previously described (Sassa et al., 1990; Abreu
et al., 2000), using an Hansatech electrode. In these experiments
mitochondrial suspensions (1 mg/ml) were incubated in 2.5 ml of
peroxidation medium containing 175 mM KCl, 10 mM Tris–HCl
(pH 7.4), supplemented with 3 lM rotenone. The lipid peroxida-
tion was initiated by the simultaneous addition of 1 mM ADPand 0.1 mM FeSO4. When present, the compounds were incubated
2 min before the induction of lipid peroxidation.
2.7.2. TBARS assay
The determination of the amount of thiobarbituric acid
reactive substances (TBARS) was performed following the
method described by Rohn et al., 1993, with some modifications.
The reactions previously described for monitoring oxygen
consumption associated with lipid peroxidation, were also used
to quantify the amount of TBARS. So, at selected time intervals,
aliquots of 450 ll were collected from the incubation chamber
and mixed with 500 ll of ice cold trichloroacetic acid (TCA)
40%, to stop the lipid peroxidative reaction and again mixed with
2 ml of thiobarbituric acid (TBA) 0.67%. The mixture was heated
at 100 C, during 15 min, and re-cooled on ice for 10 min more.
The samples were then centrifuged at 1500g, for 8 min (centri-
fuge Sorvall RT6000). The supernatants were collected and the
absorbance was read at 530 nm, against a blank, using a spectro-
photometer Bausch & Lamb, Spectronic 21. The final amount of
TBARS was calculated using a molar extinction coefficient of
1.56  105 M1 cm1 and expressed as nmol TBARS/mg protein
(Buege and Aust, 1978).
2.7.3. Mitochondrial DW collapse
The collapse of DW promoted by ADP/Fe2+ in energized rat liver
mitochondria was monitored using the TPP+ electrode. In these
experiments, mitochondria (1.5 mg/ml) were incubated at 30 C,
in 1 ml of peroxidation medium containing 175 mM KCl, 10 mM
Tris–HCl (pH 7.4), supplemented with 3 lM TPP+, 3 lM rotenone
and 1.5 lM oligomycin. Mitochondria were energized with 5 mM
succinate. After mitochondria’s incubation with the compounds,
for 2 min, the lipid peroxidation was induced by the simultaneous
addition of ADP (1 mM) and FeSO4 (0.1 mM) and DW followed
along the time.
2.8. Cell culture
In this work, 2 different cells lines, L929 fibroblasts and PC12
cells, were used. The L929 has been considered as a user-friendly
model for viability studies (Fischer et al., 2003) and was used just
to assess the compounds toxicity. Cells obtained from ECACC were
grown in 75 cm2 tissue culture flasks, in DMEM medium supple-
mented with 10% (v/v) heat-inactivated fetal bovine serum (FBS)
and 1% (v/v) of an antibiotic/antimycotic solution containing
10,000 units of penicillin, 10 mg streptomycin and 25 lg ampho-
tericin B per ml.
The PC12 cell line, established from a rat adrenal pheochro-
mocytoma is a neuronal cell model, usually used to study phe-
nomena related with oxidative stress (Pereira et al., 1999; Silva
et al., 2006). The PC12 cells were grown in RPMI-1640, supple-
mented with 10% (v/v) heat-inactivated horse serum, 5% (v/v)
heat-inactivated FBS and 1% (v/v) antibiotic/antimycotic solution
(as described above). Before experiments cells, which grow in
suspension, were carefully separated by gently pipetting and pla-
ted in multi-wells previously coated with poly-D-lysine (0.1 mg/
ml) to promote cell adherence.
Both cell lines were kept at 37 C in an incubator with a humid-
ified atmosphere and 5% CO2.
2.9. Cell viability test
Cell viability was determined by the MTT reducing test follow-
ing the method described by Mosmann, 1983. The L929 cells were
plated at 5  105 cells/ml (0.5 ml/well) and left for adhesion during
5 h. After overnight incubation with the compounds the cells were
washed with Krebs medium containing 140 mM NaCl, 5 mM KCl,
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at pH 7.4. The cells were then incubated with 500 ll MTT (final
concentration 0.5 mg/ml, in Krebs medium) for 2 h. In order to dis-
solve the formazan crystals, 0.04 M hydrogen chloride, in isopropa-
nol, was added to each well. The plate was then covered with
aluminium foil and put on orbital shaking 2 h more. After careful
dissolution of formazan crystals the absorbance was measured at
570 nm in a microplate reader Spetra Max 340PC. The percentage
of viability was calculated towards a control value obtained in
the presence of the compounds solvent, DMSO, alone. A positive
control of cells treated with 5 mM H2O2 was also done.
2.10. Measurement of cellular TBARS
The method used for TBARS measurements was previously
described (Agostinho et al., 1997; Silva et al., 2006) with some
modifications. PC12 cells were plated in poly-D-lysine coated 6-
well plates at a density of 1.3  106 cells/ml (2 ml for each well)
and left for adhesion overnight. The following day, cells were
washed with Krebs medium (pH 7) and incubated for 30 min more
with the compounds in a final volume of 2 ml of Krebs medium (pH
7), supplemented with 100 lM EGTA. After this incubation period,
the lipid peroxidation was induced by adding the oxidant pair
2 mM ascorbate/0.2 mM FeSO4, for 30 min. The medium was then
removed and the reaction stopped by adding, 600 ll of ice-cold
15 mM Tris, pH 7.4, per well, to lyse the cells. Disrupted cells were
scrapped from each well and the contents of two of them, in the
same experimental condition, were pooled. To quantify TBARS for-
mation, 1 ml of each pool was mixed with 2 ml of a solution con-
taining 0.38% TBA (w/v), 37.5% TCA (v/v) and 0.015% butylated
hydroxitoluene (BHT) (w/v), boiled for 15 min, cooled off on ice
and centrifuged at 3000 rpm for 10 min. The absorbance of the
supernatants was measured at 530 nm in a Spectra Max 340PC
microplate reader.
The TBARS concentration, that is MDA equivalents that react
with the TBA reagent (Girotti, 1998), was calculated by using the
following equation: CTBARS = (V  OD530 nm)/(e mg (protein)  l),
where V represents the dilution factor, l the thickness of the well
(0.753 cm) and e the molar extinction coefficient
(1.56  105 M1 cm1). The amount of protein was estimated in
each sample by the Bradford method, with BSA as standard, and
the results expressed in terms of nmol TBARS/ mg protein.
2.11. Determination of radical scavenging capacity—DPPH assay
The radical scavenging capacity of the compounds was mea-
sured by the DPPH (2,2-diphenil-1-picrylhydrazyl) assay described
by Silva et al., 2006. This method is based on the evaluation of the
capacity of a compound to reduce the DPPH radical.
Samples of different compounds concentrations (10 ll of each,
in triplicate) were placed in a 96-well plate and mixed with
180 ll of a 0.002% ethanolic DPPH solution. The absorbance of
the mixture was monitored during 60 min, at 517 nm, in a Spectra
Max 340PC microplate reader. A Trolox solution and a control with
the drug solvent alone (DMSO) were also prepared. The colour of
the adequate control was considered as 100%. The IC50 value was
determined from the dose response-curve of the percentage of
DPPH discoloration.
2.12. Determination of iron chelation capacity
The compounds capacity to chelate iron (Fe3+) was determined
spectrophotometrically, according to the method described by
Mira et al., 2002. The absorption spectra of the compound’s solu-
tion (100 lM) were read at both pH 7.4 (in 20 mM HEPES buffer)
and pH 5.5 (in 50 mM potassium acetate buffer), at room temper-ature, between 200 and 600 nm, in a spectrophotometer
Perkin Elmer Lambda 2 UV/vis. The absorption spectra of the com-
pounds combined with FeCl3 (100 lM) were also measured. Both
spectra were run against appropriate blanks.
2.13. Statistical analysis
The results were expressed as mean ± SEM of the number of
experiments (n) indicated in the legend of each figure. The statisti-
cal significance was determined by using a one-way ANOVA, fol-
lowed by a Newman–Keuls post-hoc test. P values 6 0.05 were
considered as statistically significant.3. Results
3.1. Compounds effect on mitochondrial lipid peroxidation
The antioxidant capacity of MJQ1 and MJQ2 was investigated in
non-energized mitochondria submitted to severe oxidative stress
induced by the oxidant pair ADP/Fe2+. The compounds effect on
lipid peroxidation was evaluated through mitochondrial oxygen
consumption and by the TBARS assay as described elsewhere
(Abreu et al., 2000). The compounds capacity of protecting
mitochondrial membranes from electrical gradient (DW) collapse,
induced by the same oxidant pair, was also evaluated (Figs. 2–4).
3.2. Oxygen consumption monitorization
Results on Fig. 2A show that MJQ1 concentrations up to
32 pmol/mg protein (32 nM), prolonged the initial time (lag-time)
of oxygen consumption with increasing drug concentrations, but
did not alter the oxygen consumption related with the propagation
phase of lipid peroxidation. The MJQ1 concentration of 48 pmol/
mg protein (48 nM) totally inhibits the oxygen consumption, so
at this concentration the antioxidant activity can be considered
as maximal.
In Fig. 2B, MJQ2 concentrations of 25 and 38 nmol/mg protein
(25 and 38 lM, respectively) prolonged the lag-time but had no ef-
fect on posterior oxygen consumption rate. A MJQ2 concentration
of 56 nmol/mg protein (56 lM) completely inhibits the oxygen
consumption, which means maximal antioxidant activity for a con-
centration 1000 times greater than the one effective for MJQ1.
3.3. TBARS production and IC50 determination
In order to confirm the compounds antioxidant activity
observed, by oxygen consumption experiments, the malondialde-
hyde (MDA) production was also followed in the same experimen-
tal conditions, for 30 min.
Results in Fig. 3 confirmed the protective effect of both
compounds on lipid peroxidation, represented by the decrease in
thiobarbituric acid-reactive substances (TBARS) formation, along
the time (30 min). A similar profile of protection was obtained by
monitorization of TBARS and oxygen consumption shown in Fig. 2.
Data from Fig. 3 allowed us to calculate the IC50 values, which
are the concentration required for 50% inhibition of TBARS produc-
tion. We found IC50s of 23.5 nM and 30 lM for MJQ1 and MJQ2,
respectively. MJQ1 is much more potent in the protection against
lipid peroxidation than MJQ2. Comparing these IC50 values with
the one obtained for Trolox, in the same experimental conditions
(18.8 lM, reported by Abreu et al., 2000) we can say that MJQ1
is clearly more potent than that reference compound.
The compound’s concentration range chosen for the subsequent
studies is based on the concentration at which each compound
inhibited mitochondrial lipid peroxidation.
Fig. 2. Effect of MJQ1 (A) and MJQ2 (B) on the oxygen consumption due to lipid peroxidation induced by ADP/Fe2+ in mitochondria. Mitochondria (1 mg/ml) were incubated
in medium, supplemented with 3 lM rotenone, in the absence (control) and in the presence of increasing concentrations of diarylamines in study, for 2 min. The pair 1 mM
ADP/0.1 mM FeSO4 was added to initiate the lipid peroxidation. The compounds concentration was indicated at the end of each record. In this experimental conditions
48 pmol(MJQ1)/mg corresponds to 48 nM and 56 nmol (MJQ2)/mg corresponds to 56 lM. These figures are representative of 6 independent experiments using 3 different
mitochondrial preparations.
Fig. 3. Effects of MJQ1 (A) and MJQ2 (B) on TBARS formation due to lipid peroxidation in mitochondrial membranes. Experimental conditions are the same as in Fig. 2. At each
time point samples were collected, from the incubation chamber, for TBARS assay. This figure is representative of 6 independent experiments using 3 different mitochondrial
preparations.
Fig. 4. Effects of MJQ1 (A) and MJQ2 (B) on mitochondrial DW decrease induced by ADP/ Fe2+. Mitochondria were incubated in peroxidation medium, supplemented with
3 lM TPP+, 3 lM rotenone and 1.5 lg/ml oligomycin. After 2 min energization with succinate (5 mM), in the absence (control) or in the presence of the diarylamines, the lipid
peroxidation was induced by addition of the oxidant pair. The compounds concentrations are indicated at the end of each record. In these experimental conditions 80 pmol
(MJQ1)/mg corresponds to 120 nM and 100 nmol (MJQ2)/mg corresponds to 150 lM. This figure is representative of 6 independent experiments using 3 different
mitochondrial fractions.
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Mitochondrial inner membrane disruption induces a proton-
motive force (Dp) collapse, in which the electrical gradient (DW)
is the main component. Thus, the continuous registration of DW
fluctuations, in mitochondria subjected to severe oxidative stress,
constitutes an excellent instrument to follow the protective effects
of antioxidants (Abreu et al., 2000). Fig. 4 shows effects of MJQ1
and MJQ2, at different concentrations, on the mitochondrial DW
fluctuations associated with the respiratory process, in the pres-
ence of the oxidant pair ADP/Fe2+. Mitochondria were energizedwith succinate in the presence of oligomycin, to prevent the depo-
larization that occurs in normal conditions, at the moment of ADP
addition.
The addition of the oxidant pair ADP/Fe2+ results in a DW col-
lapse, attributed to membrane disruption induced by lipid peroxi-
dation (Fig. 4) This effect was verified after a lag-phase, which may
correspond to the time needed to produce a significant amount of
ROS, enough to initiate the lipid peroxidation cascade.
Still in Fig. 4 we can observe that the compounds in study had a
protective effect, preventing the DW collapse in oxidative stress
conditions, in a dose-dependent manner. During the time period
22 D. Pinto-Basto et al. /Mitochondrion 9 (2009) 17–26considered, 30 min, MJQ1 had a maximal protection at a concen-
tration of 80 pmol/mg protein (120 nM), whereas MJQ2 is effective
for 100 nmol/mg protein (150 lM). It can also be observed that
increasing compounds concentrations promote a small decline in
maximalDW value, which is more evident in the presence of MJQ2.
3.5. Effects on respiratory parameters as a measure of compounds
toxicity in mitochondria
From the continuous recording of oxygen consumption, in the
presence of different substrates, we obtained the respiratory
parameters RCR and ADP/O ratio (Table 1). The RCR control values
are indicative of the purity and intactness of mitochondria.
The compound MJQ1 slightly affected the RCR index (with suc-
cinate as electron donor) only for a concentration of 80 pmol/mg
protein (120 nM), which is substantially higher than the concen-
tration at which it exhibited maximal antioxidant activity
(48 pmol/mg protein or 48 nM). It should be noted that for this
concentration the ADP/O ratio remained unchanged, indicating
that mitochondrial phosphorylative efficiency remains unaltered.
On the other hand, the compound MJQ2, at a concentration of
50 nmol/mg protein, significantly depressed the RCR and ADP/O in-
dexes, when mitochondria were energized with glutamate/malate,
as respiratory substrates. This effect on both respiratory parame-
ters suggests an interference of MJQ2 with mitochondrial
bioenergetics.
In order to obtain a more precise indication about mitochon-
drial targets for these compounds, the following respiratory veloc-
ities were evaluated: state 3 respiratory velocity (V3), state 4
respiratory velocity (V4), respiratory velocity in the presence of oli-
gomycin (VOlig) and in the presence of FCCP (VFCCP), using gluta-
mate/ malate and succinate as respiratory substrates (Fig. 5), as
previously done by Du and collaborators (Du et al., 1998).
So, as can be observed in Fig. 5A and B, the MJQ1 compound did
not change any respiratory rates studied, for concentrations up to
80 pmol/mg protein (120 nM), using glutamate/malate and succi-
nate as respiratory substrates.
For a MJQ2 concentration of 50 nmol/mg protein (75 lM), there
seems to be a trend to affect both the state 3 respiratory rate (V3)
and the respiratory rate in the presence of FCCP (VFCCP), using glu-
tamate/malate as the respiratory substrate (see Fig. 5C) although
not statistically significant, whereas with succinate, V3 and VFCCP
did not change at all (see Fig. 5D). According to Du and collabora-
tors a significant and simultaneous decrease of V3 and VFCCP indi-
cates that the compound interacts with some respiratory chain
component. Therefore, we suggest that MJQ2 might be able toTable 1
Effects of MJQ1 and MJQ2 on the respiratory indexes.
Glutamate/Malate Succinate
RCR ADP/O RCR ADP/O
MJQ1 (pmol/mg)
0 7.26 ± 0.37 3.40 ± 0.04 5.69 ± 0.36 1.95 ± 0.05
13 7.32 ± 0.26 3.45 ± 0.10 5.36 ± 0.44 1.89 ± 0.07
27 7.01 ± 0.28 3.41 ± 0.01 5.34 ± 0.50 1.94 ± 0.05
40 7.20 ± 0.47 3.47 ± 0.14 4.91 ± 0.27 2.02 ± 0.04
80 7.25 ± 0.81 3.44 ± 0.16 *4.23 ± 0.08 1.94 ± 0.03
MJQ2 (nmol/mg)
0 7.41 ± 0.54 3.27 ± 0.04 4.90 ± 0.28 1.76 ± 0.04
25 *4.81 ± 0.41 3.17 ± 0.03 4.62 ± 0.87 1.73 ± 0.04
50 *3.95 ± 0.26 **3.06 ± 0.03 *3.70 ± 0.31 1.65 ± 0.07
Respiratory control ratio (RCR) and ADP/Oxygen ratio where evaluated in rat liver
mitochondria energised with glutamate/malate and succinate. The values are
means ± SEM of 3 independent experiments using 3 different mitochondrial frac-
tions (*p 6 0.05, **p 6 0.01, compared with the control, in the absence of
compounds).affect the electron flux at complex I level at concentrations supe-
rior to 75 lM, that is, much higher than the concentration at which
MJQ2 shows maximal antioxidant activity (50 lM).
3.6. Electrical potential (DW) fluctuations related to the respiratory
and phoshorylation cycle
We also investigated the effects of the diarylamines in the mito-
chondrial DW associated with respiration and with the phosphor-
ylation cycle, as an indication of compounds toxicity to
mitochondria.
In the control situation (Fig. 6A and B), mitochondria developed
a DW near 215 mV, generated by mitochondrial respiration sus-
tained by the respiratory substrates glutamate/malate and succi-
nate (state 4). The addition of ADP promoted the immediate
membrane depolarization, reflected by a DW reduction of about
30 mV (state 3). This depolarization induced by the ADP addition
results from the use of Dps energy, by the ATP synthase. The pro-
tons flux turning back, through the ATP synthase, gives the energy
necessary to ADP phosphorylation. Following this ADP phosphory-
lation the DW is recovered to the initial level (repolarization
phase), after a short period of time, which is dependent on the
amount of ADP present.
Data on Fig. 6A also shows that MJQ1 concentrations up to
3.3 nmol/mg protein (50 lM) did not affect the depolarization/
repolarization curves with both respiratory substrates used. It is
important to notice that this concentration is higher then the max-
imal MJQ1 concentration that exhibited mitochondrial antioxidant
activity (48 pmol/mg protein, 48 nM). However, MJQ2 concentra-
tions of 33 and 50 nmol/mg protein (50 and 75 lM, respectively),
promoted a small decrease in potential, related to the respiration
and also depressed the phosphorylation cycle kinetic (mitochon-
dria take more time to phosphorylate the ADP present).
The comparative results of both compounds, obtained in mito-
chondria, allow us to bring out MJQ1 as the promising compound,
safer and very powerful against oxidative stress conditions.
3.7. Effects on cell survival
The cytotoxicity of the compounds was then evaluated in a
whole cell model using the fibroblast L929 cell line and the MTT
reduction assay. Results in Fig. 7 show that the two diarylamines
did not affect the cell viability for concentrations up to 100 lM.
Even at this high concentration (100 lM) MJQ1 does not affect cell
viability. The same concentration of MJQ2 reduces the cell viability
to 89.4%. In both cases the concentrations tested are higher than
the concentrations at which the compounds proved to have antiox-
idant properties in mitochondria (50 nM MJQ1 and 60 lM MJQ2).
However, the results indicate some toxicity for MJQ2, which is in
agreement with the observed effects on bioenergetic parameters.
The following experiments were focused on the MJQ1 antioxi-
dant potential and on the elucidation of its mechanism of action.
3.8. Effect on whole cells lipid peroxidation
The effect of the MJQ1 compound on the protection against cell
lipid peroxidation was performed using the PC12 cell line. The pair
ascorbate/Fe2+ was used as the oxidant insult, as in other studies
with neuronal cell models (Ferreira et al., 1997; Rego et al., 1998).
Fig. 8 shows TBARS quantification in the presence of the oxidant
pair alone or in combination with 50 nM of MJQ1. In this last con-
dition, the protection against lipid peroxidation is clearly evident
(about 76%). Thus, MJQ1, besides conferring a considerable protec-
tion against mitochondrial lipid peroxidation (Figs. 2 and 3), also
confers an evident protection against cellular lipid peroxidation
at the same concentration.
Fig. 5. Effect of MJQ1 and MJQ2 on mitochondrial respiratory velocities. Mitochondria were incubated in reaction medium, during 2 min, at 30 C, in the absence or in the
presence of different compounds’ concentrations. Glutamate /malate (A) and (C), or succinate (B) and (D) were used as substrates. ADP (125–250 nmol), oligomycin (4 lg/ml)
and FCCP (0.5 lM) were added as indicated. This figure is representative of 6 independent experiments using 3 different mitochondrial fractions.
Fig. 6. Effects of MJQ1 (A) and MJQ2 (B) on the mitochondrial potential fluctuations (DW) associated with oxidative phosphorylation. Mitochondria were incubated in
reaction medium, supplemented with TPP+ 3 lM and rotenone 3 lM (when succinate was the substrate) during 2 min, at 30 C. The phosphorylation cycle was initiated by
adding 125 nmol ADP. The compounds concentrations were indicated at the beginning of each record. The numbers that appeared along the records indicate the DW value
(mV) measured in each moment. This figure is representative of 6 independent experiments using 3 different mitochondrial fractions.
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The radical scavenging capacity of MJQ1 was evaluated by the
DPPH radical reduction method.
Results on Fig. 9 show an increase in DPPH discoloration as a
function of the MJQ1 (1–100 lM) and Trolox (1–20 lM) concentra-
tions. The IC50s found are indicative of a DPPH radical scavenging
activity of MJQ1 similar to the standard antioxidant Trolox.
As the iron chelation ability could account for compounds’ anti-
oxidant capacity, in biological systems, we tried to understand if
this is the case of MJQ1. So, the formation of the complex ‘‘iron-
dyarylamine” was analysed by following the absorption spectra
in the presence or absence of FeCl3. Results in Fig. 10 show no dif-ference between the absorption spectra of the compound in the
presence and in the absence of iron ions (Fe3+), indicating that
the antioxidant mechanism of this diarylamine does not seem to
be mediated by its iron ions (Fe3+) chelating ability.
4. Discussion
We tried to characterize the antioxidant activity of new
synthetic diarylamines available in our lab, with the objective of
finding active principles that could be helpful either in prevention
or in treatment of oxidative stress related diseases.
The molecules in study have in common a benzo[b]thiophene
nucleus but also exhibit some structural differences that proved
Fig. 7. Cellular viability assessed by the MTT reduction test. L929 cells (5  105
cells/ml) were incubated overnight, in the absence and in the presence of increasing
concentrations of diarylamines. MTT (0.5 mg/ml) was added for 2 h more. The cell
viability was calculated as a percentage of the absorbance values read at 570 nm,
relative to a control containing the drug solvent DMSO. A positive control with
5 mM H2O2 was also done. Each column represents the mean values ± SEM of 3
independent experiments (***p 6 0.001, compared to control).
Fig. 8. Effect of MJQ1 on lipid peroxidation induced by 2 mM ascorbate/0.2 mM
Fe2+. PC12 cells were plated at density 2.6  106 in Krebs medium (pH 7),
supplemented with EGTA (100 lM). Incubation with the compound (0.05 lM)
occurred for 30 min. Lipid peroxidation was induced by subsequent addition of the
oxidant pair. TBARS levels were calculated using the absorbance values obtained at
530 nm, corrected for the protein concentration in each one. The values are the
mean ± SEM of 3 determinations. (***p 6 0.001, compared to control and
+++p 6 0.001, compared to cells exposed to the oxidant pair).
Fig. 9. Dose response curves for DPPH reduction by MJQ1 and Trolox. Different
concentrations of MJQ1 and Trolox were added to an ethanolic solution of DPPH.
The discoloration of DPPH radical was measured spectrophotometrically, at
517 nm, during 60 min. The values are the mean ± SEM of 3 independent
determinations.
Fig. 10. Absorption spectra of MJQ1 and MJQ2 in the presence and absence of FeCl3.
The absorption spectra were measured for 100 lM solutions of each compound, in
HEPES buffer at pH 7.4. Each spectrum is representative of, at least, 3 different
experiments.
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idant activity in biological models.The oxidative damage induced by reactive species in the cellular
membranes, is a key event associated with oxidative stress condi-
tions. Mitochondria are particularly susceptible to lipid peroxida-
tion, since they have a high concentration of polyunsaturated
fatty acids and also due to the membrane proximity to ROS gener-
ated by the electron transport chain (Kowaltowski and Vercesi,
1999). In this study diarylamines’ protection of lipid peroxidation
was first evaluated in mitochondria through the oxygen consump-
tion monitorization and also through quantification of TBARS.
The pair ADP/FeSO4, used as the oxidant insult, has particular
relevance in mitochondrial lipid peroxidation induction because,
in situations of mitochondrial dysfunction, there is an accumula-
tion of ADP, as a result of mitochondrial ATP synthesis inhibition,
as well as release of iron from the respiratory complexes. There-
fore, in the presence of an excess of oxygen (for example during
an ischemia/reperfusion condition) ADP and FeSO4 could lead to
the production of perferryl complex (ADP–Fe3+–O2), that can ini-
tiate lipid peroxidation (Kogure et al., 1998).
When lipid peroxidation is monitored through oxygen con-
sumption two stages can be observed: the first one related to the
generation and accumulation of this perferryl complex (ADP–
Fe3+–O2), in the proximity of the membrane surface; the second
stage is related with radical chain reactions, due to the ROS attack
of unsaturated acyl chains inside the lipid bilayer.
Both compounds in study prolonged the lipid peroxidation lag-
time (Fig. 2) so, apparently, they both inactivate ROS at/near the
membrane surface. This effect is similar to that observed for BHT
(butylated hydroxytoluene), a lipophilic antioxidant compound
used as food stabilizer (Kogure et al., 1998). The same study also
shows that, contrary to BHT, a-tocopherol inhibits the propagation
phase of radical chain reactions without affecting the lag-time,
which indicates a specific action inside the lipid bilayer.
The MJQ1 and MJQ2 concentrations that led to a higher lipid
peroxidation protective effect were 48 pmol/mg protein (50 nM)
and 56 nmol/mg protein (60 lM), respectively (Fig. 2). Despite
both diarylamines presenting an evident antioxidant activity,
MJQ1 acts at much lower concentrations (nanomolar), compared
with MJQ2 that acts at micromolar concentrations.
The compounds protection on mitochondrial lipid peroxidation,
assessed by the TBARS method, confirms an effective antiperoxida-
tive effect for both compounds (Fig. 3). Again MJQ1 compound is
effective for a much lower concentration than MJQ2 and has an
IC50 value even better than that obtained for the reference com-
pound Trolox, in the same experimental conditions.
Results in Fig. 4 show that increasing diarylamines’ concentra-
tions prevent the DW collapse promoted by ADP/FeSO4. This result
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pounds are able to preserve the mitochondria integrity, which is
a crucial factor to maintain cell viability.
To evaluate the compounds mitochondrial toxicity we used a
classical methodology in which bioenergetics parameters were
evaluated (RCR and ADP/O ratio). The compound MJQ1 did not im-
pair the mitochondrial bioenergetics at concentrations that have
denoted antioxidant activity (Table 1). The slight RCR decrease ob-
served for 80 pmol/mg protein (120 nM) is not accompanied by an
effect on the ADP/O ratio, so should not be interpreted as evidence
of any toxic effect, as also observed by others (Ferreira and Gil,
1984; Santos et al., 2002). On the other hand, the compound
MJQ2 at a concentration of 50 nmol/mg protein (75 lM), affected
the RCR parameter, in the presence of both substrates used and
also the ADP/O ratio in the presence of glutamate/malate (Table
1). This means an effect on the mitochondrial phosphorylation effi-
ciency, although 75 lM is slightly higher than the concentration at
which MJQ2 had denoted maximal antioxidant activity (60 lM).
This was the first indication of the superiority of MJQ1 compared
with MJQ2, certainly related with the structure modification intro-
duced in the first one.
The comparative study between respiratory velocities, in the
presence and in the absence of the compounds, allows the under-
standing of the mechanisms of action of these molecules at the
respiratory chain components level. The compounds effect, ob-
served on the respiratory velocities (V3, V4, VOlig and VFCCP), again
indicates the superiority of MJQ1 compared with MJQ2. The first
one did not affect any of the above mentioned velocities, whereas
MJQ2 shows a trend to decrease V3 and VFCCP, when glutamate/ma-
late is the electron donor. This suggests that high concentrations of
MJQ2 (>75 lM) may affect particularly the complex I of mitochon-
dria respiratory chain, although this effect deserves to be further
explored.
The monitorization of transmembrane potential (DW) fluctua-
tions, associated with mitochondrial respiration and the phosphor-
ylation cycle, is a powerful instrument for toxicity assessment,
since the DW represents the main component of the electrochem-
ical gradient.
From Fig. 6A we can say that MJQ1 does not change the fluc-
tuations of DW characteristic of mitochondrial respiration and
phosphorylation cycle. In opposition, MJQ2 promotes a little de-
crease on maximal DW associated to the respiration and a delay
in the normal phosphorylation time, in the presence of both
electron donors used (Fig. 6B). It has been suggested (Korshunov
et al., 1997) that small decreases (10%) in the mitochondrial
DW are responsible for the effective decrease in ROS produc-
tion. Considering these results, the small DW decrease pro-
moted by MJQ2 may be explained as a MJQ2 protective effect
on mitochondrial ROS production, but this effect has to be clar-
ified to rule out a compound’s effect on mitochondrial
bioenergetics.
The results above mentioned, obtained with isolated mitochon-
dria, were complemented with some studies in whole cells.
We found no toxicity at all for all the MJQ1 concentrations
tested (Fig. 7), which confirm the results obtained with mitochon-
dria. MJQ2, in turn, decreased the cell viability in the concentration
range of its maximal antioxidant activity in mitochondria (60 lM),
however with a variance not statistically significant. The results ta-
ken together provide evidence for the safer profile of MJQ1 com-
pared to MJQ2.
The protective effects of MJQ1 on lipid peroxidation were also
evaluated in a whole cell model. In this case we used the PC12 cell
line, in which the oxidative damage has been correlated with that
occurring in neurodegenerative diseases (Pereira et al., 1999). Lipid
peroxidation was, in this case, induced by the oxidant pair ascor-
bate/iron, considering the significant amounts they both can reachin brain tissue and also following the methodology used in other
studies with neuronal cell models (Cardoso et al., 1998; Rego
et al., 1998; Silva et al., 2006).
The results obtained confirm an evident MJQ1 protective effect
against lipid peroxidation at the cellular level (Fig. 8) for the same
concentration previously shown to have maximal antioxidant
activity in the mitochondrial model (50 nM).
In this respect MJQ1 emerges as a most promising one with
beneficial effects in a nanomolar range. On the other hand, protec-
tion of PC12 cells against lipid peroxidation indicates that their tar-
get is not only the mitochondrial membranes, but also the plasma
membrane. Such a protective effect in a neuronal cell model
encourages us to further investigate other cellular targets for this
compound with implications in neurodegeneration for example,
and clearly indicates that the modification introduced in MJQ1
structure resulted in a clear improvement of the biological activity
of this diarylamine.
The results obtained with the DPPH discoloration method al-
lowed us to conclude that MJQ1 has a scavenging activity close
to the reference standard Trolox, with both IC50 values close to
10 lM (Fig. 9). This fact indicates that the transference of H,
by homolytic breakdown of NAH bond, could be the antioxidant
action mechanism of this compound. The electron-donating ef-
fect of methoxyl group (OMe) by mesomeric effect, as well as
the inductive effect of methyl group (CH3), on the seventh posi-
tion of the benzo[b]thiophene, could also contribute to this scav-
enging effect of MJQ1. MJQ2 has not the ability to scavenge the
DPPH radical (results not shown), possibly due to the presence
of an ester group on the thiophene ring (which acts as an elec-
tron-withdrawer by a mesomeric effect) and to the pyridine ring,
poor in electrons.
The antioxidant capacity of any compound besides being re-
lated with the hydrogen atom transfer reaction, could also be
due to its capacity to quelate metal ions and/or inhibit oxidative
enzymes. Some investigators have proposed the participation of
perferryl complex (ADP–Fe3+–O2) in the initiation and propaga-
tion of lipid peroxidation, which also require the presence of oxy-
gen and free iron (Kogure et al., 1998). So, the presence of
molecules with the ability to chelate metal ions could reduce the
reactive species and, consequently, protect lipid membranes
against peroxidation. It has been already demonstrated that desfer-
rioxamine, an iron (Fe3+) chelator, limits the amount of free radical
production in several different cells and species (Mira et al., 2002;
Pardo et al., 2005).
Our results (Fig. 10) showed that there are no changes in the
spectra, obtained in the presence or absence of FeCl3, which mean
that the antioxidant activity verified for MJQ1 does not seem to be
due to their iron chelator properties. Considering that low pH val-
ues can be generated during the iron release by oxidized proteins,
or in generic processes like phagocytosis, inflammation or during
the ischemia/reperfusion injury (Mira et al., 2002), we also looked
for spectra alterations at pH 5.5, but again no difference was ob-
served (results not shown).
In conclusion, the new diarylamines show antioxidant activity
for non-toxic concentrations, protecting the mitochondrial and cell
membranes against lipid peroxidation induced by appropriate del-
eterious agents.
The structural modification introduced in the chemical struc-
ture that resulted in the MJQ1 compound, clearly improved both
its antioxidant and toxicity profile. More research is needed to elu-
cidate other intracellular targets and better understand the mech-
anisms of action of these new molecules. Nevertheless, the results
herein presented are of great importance because they open new
perspectives for the development of MJQ1 and related compounds
as active principles of drugs eventually useful in conditions where
oxidative stress is involved.
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